Request for Covid-19 Impact Assessment of this Report
The United States Buprenorphine Transdermal Patches market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Buprenorphine Transdermal Patches market, reaching US$ million by the year 2028. As for the Europe Buprenorphine Transdermal Patches landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Buprenorphine Transdermal Patches players cover Grunenthal, PurduePharma, Luye Pharma, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Transdermal Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
5mcg/h
7.5mcg/h
10mcg/h
15 mcg/h
20 mcg/h
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Relieve Cancer Pain
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Grunenthal
PurduePharma
Luye Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Buprenorphine Transdermal Patches Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Buprenorphine Transdermal Patches by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Buprenorphine Transdermal Patches by Country/Region, 2017, 2022 & 2028
2.2 Buprenorphine Transdermal Patches Segment by Type
2.2.1 5mcg/h
2.2.2 7.5mcg/h
2.2.3 10mcg/h
2.2.4 15 mcg/h
2.2.5 20 mcg/h
2.3 Buprenorphine Transdermal Patches Sales by Type
2.3.1 Global Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)
2.3.2 Global Buprenorphine Transdermal Patches Revenue and Market Share by Type (2017-2022)
2.3.3 Global Buprenorphine Transdermal Patches Sale Price by Type (2017-2022)
2.4 Buprenorphine Transdermal Patches Segment by Application
2.4.1 Relieve Cancer Pain
2.4.2 Other
2.5 Buprenorphine Transdermal Patches Sales by Application
2.5.1 Global Buprenorphine Transdermal Patches Sale Market Share by Application (2017-2022)
2.5.2 Global Buprenorphine Transdermal Patches Revenue and Market Share by Application (2017-2022)
2.5.3 Global Buprenorphine Transdermal Patches Sale Price by Application (2017-2022)
3 Global Buprenorphine Transdermal Patches by Company
3.1 Global Buprenorphine Transdermal Patches Breakdown Data by Company
3.1.1 Global Buprenorphine Transdermal Patches Annual Sales by Company (2020-2022)
3.1.2 Global Buprenorphine Transdermal Patches Sales Market Share by Company (2020-2022)
3.2 Global Buprenorphine Transdermal Patches Annual Revenue by Company (2020-2022)
3.2.1 Global Buprenorphine Transdermal Patches Revenue by Company (2020-2022)
3.2.2 Global Buprenorphine Transdermal Patches Revenue Market Share by Company (2020-2022)
3.3 Global Buprenorphine Transdermal Patches Sale Price by Company
3.4 Key Manufacturers Buprenorphine Transdermal Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Buprenorphine Transdermal Patches Product Location Distribution
3.4.2 Players Buprenorphine Transdermal Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Buprenorphine Transdermal Patches by Geographic Region
4.1 World Historic Buprenorphine Transdermal Patches Market Size by Geographic Region (2017-2022)
4.1.1 Global Buprenorphine Transdermal Patches Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Buprenorphine Transdermal Patches Annual Revenue by Geographic Region
4.2 World Historic Buprenorphine Transdermal Patches Market Size by Country/Region (2017-2022)
4.2.1 Global Buprenorphine Transdermal Patches Annual Sales by Country/Region (2017-2022)
4.2.2 Global Buprenorphine Transdermal Patches Annual Revenue by Country/Region
4.3 Americas Buprenorphine Transdermal Patches Sales Growth
4.4 APAC Buprenorphine Transdermal Patches Sales Growth
4.5 Europe Buprenorphine Transdermal Patches Sales Growth
4.6 Middle East & Africa Buprenorphine Transdermal Patches Sales Growth
5 Americas
5.1 Americas Buprenorphine Transdermal Patches Sales by Country
5.1.1 Americas Buprenorphine Transdermal Patches Sales by Country (2017-2022)
5.1.2 Americas Buprenorphine Transdermal Patches Revenue by Country (2017-2022)
5.2 Americas Buprenorphine Transdermal Patches Sales by Type
5.3 Americas Buprenorphine Transdermal Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Buprenorphine Transdermal Patches Sales by Region
6.1.1 APAC Buprenorphine Transdermal Patches Sales by Region (2017-2022)
6.1.2 APAC Buprenorphine Transdermal Patches Revenue by Region (2017-2022)
6.2 APAC Buprenorphine Transdermal Patches Sales by Type
6.3 APAC Buprenorphine Transdermal Patches Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Buprenorphine Transdermal Patches by Country
7.1.1 Europe Buprenorphine Transdermal Patches Sales by Country (2017-2022)
7.1.2 Europe Buprenorphine Transdermal Patches Revenue by Country (2017-2022)
7.2 Europe Buprenorphine Transdermal Patches Sales by Type
7.3 Europe Buprenorphine Transdermal Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Buprenorphine Transdermal Patches by Country
8.1.1 Middle East & Africa Buprenorphine Transdermal Patches Sales by Country (2017-2022)
8.1.2 Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2017-2022)
8.2 Middle East & Africa Buprenorphine Transdermal Patches Sales by Type
8.3 Middle East & Africa Buprenorphine Transdermal Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buprenorphine Transdermal Patches
10.3 Manufacturing Process Analysis of Buprenorphine Transdermal Patches
10.4 Industry Chain Structure of Buprenorphine Transdermal Patches
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Buprenorphine Transdermal Patches Distributors
11.3 Buprenorphine Transdermal Patches Customer
12 World Forecast Review for Buprenorphine Transdermal Patches by Geographic Region
12.1 Global Buprenorphine Transdermal Patches Market Size Forecast by Region
12.1.1 Global Buprenorphine Transdermal Patches Forecast by Region (2023-2028)
12.1.2 Global Buprenorphine Transdermal Patches Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Buprenorphine Transdermal Patches Forecast by Type
12.7 Global Buprenorphine Transdermal Patches Forecast by Application
13 Key Players Analysis
13.1 Grunenthal
13.1.1 Grunenthal Company Information
13.1.2 Grunenthal Buprenorphine Transdermal Patches Product Offered
13.1.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Grunenthal Main Business Overview
13.1.5 Grunenthal Latest Developments
13.2 PurduePharma
13.2.1 PurduePharma Company Information
13.2.2 PurduePharma Buprenorphine Transdermal Patches Product Offered
13.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 PurduePharma Main Business Overview
13.2.5 PurduePharma Latest Developments
13.3 Luye Pharma
13.3.1 Luye Pharma Company Information
13.3.2 Luye Pharma Buprenorphine Transdermal Patches Product Offered
13.3.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Luye Pharma Main Business Overview
13.3.5 Luye Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Buprenorphine Transdermal Patches Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Buprenorphine Transdermal Patches Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5mcg/h
Table 4. Major Players of 7.5mcg/h
Table 5. Major Players of 10mcg/h
Table 6. Major Players of 15 mcg/h
Table 7. Major Players of 20 mcg/h
Table 8. Global Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)
Table 9. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)
Table 10. Global Buprenorphine Transdermal Patches Revenue by Type (2017-2022) & ($ million)
Table 11. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2017-2022)
Table 12. Global Buprenorphine Transdermal Patches Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)
Table 14. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)
Table 15. Global Buprenorphine Transdermal Patches Revenue by Application (2017-2022)
Table 16. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2017-2022)
Table 17. Global Buprenorphine Transdermal Patches Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Buprenorphine Transdermal Patches Sales by Company (2020-2022) & (K Units)
Table 19. Global Buprenorphine Transdermal Patches Sales Market Share by Company (2020-2022)
Table 20. Global Buprenorphine Transdermal Patches Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Buprenorphine Transdermal Patches Revenue Market Share by Company (2020-2022)
Table 22. Global Buprenorphine Transdermal Patches Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Buprenorphine Transdermal Patches Producing Area Distribution and Sales Area
Table 24. Players Buprenorphine Transdermal Patches Products Offered
Table 25. Buprenorphine Transdermal Patches Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Buprenorphine Transdermal Patches Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Buprenorphine Transdermal Patches Sales Market Share Geographic Region (2017-2022)
Table 30. Global Buprenorphine Transdermal Patches Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Buprenorphine Transdermal Patches Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Buprenorphine Transdermal Patches Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Buprenorphine Transdermal Patches Sales Market Share by Country/Region (2017-2022)
Table 34. Global Buprenorphine Transdermal Patches Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Buprenorphine Transdermal Patches Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Buprenorphine Transdermal Patches Sales by Country (2017-2022) & (K Units)
Table 37. Americas Buprenorphine Transdermal Patches Sales Market Share by Country (2017-2022)
Table 38. Americas Buprenorphine Transdermal Patches Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Buprenorphine Transdermal Patches Revenue Market Share by Country (2017-2022)
Table 40. Americas Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)
Table 41. Americas Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)
Table 42. Americas Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)
Table 43. Americas Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)
Table 44. APAC Buprenorphine Transdermal Patches Sales by Region (2017-2022) & (K Units)
Table 45. APAC Buprenorphine Transdermal Patches Sales Market Share by Region (2017-2022)
Table 46. APAC Buprenorphine Transdermal Patches Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Buprenorphine Transdermal Patches Revenue Market Share by Region (2017-2022)
Table 48. APAC Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)
Table 49. APAC Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)
Table 50. APAC Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)
Table 51. APAC Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)
Table 52. Europe Buprenorphine Transdermal Patches Sales by Country (2017-2022) & (K Units)
Table 53. Europe Buprenorphine Transdermal Patches Sales Market Share by Country (2017-2022)
Table 54. Europe Buprenorphine Transdermal Patches Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Buprenorphine Transdermal Patches Revenue Market Share by Country (2017-2022)
Table 56. Europe Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)
Table 57. Europe Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)
Table 58. Europe Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)
Table 59. Europe Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Buprenorphine Transdermal Patches Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Buprenorphine Transdermal Patches Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Buprenorphine Transdermal Patches
Table 69. Key Market Challenges & Risks of Buprenorphine Transdermal Patches
Table 70. Key Industry Trends of Buprenorphine Transdermal Patches
Table 71. Buprenorphine Transdermal Patches Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Buprenorphine Transdermal Patches Distributors List
Table 74. Buprenorphine Transdermal Patches Customer List
Table 75. Global Buprenorphine Transdermal Patches Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Buprenorphine Transdermal Patches Sales Market Forecast by Region
Table 77. Global Buprenorphine Transdermal Patches Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Buprenorphine Transdermal Patches Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Buprenorphine Transdermal Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Buprenorphine Transdermal Patches Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Buprenorphine Transdermal Patches Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Buprenorphine Transdermal Patches Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Buprenorphine Transdermal Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Buprenorphine Transdermal Patches Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Buprenorphine Transdermal Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Buprenorphine Transdermal Patches Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Buprenorphine Transdermal Patches Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Buprenorphine Transdermal Patches Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Buprenorphine Transdermal Patches Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Application (2023-2028)
Table 95. Grunenthal Basic Information, Buprenorphine Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 96. Grunenthal Buprenorphine Transdermal Patches Product Offered
Table 97. Grunenthal Buprenorphine Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Grunenthal Main Business
Table 99. Grunenthal Latest Developments
Table 100. PurduePharma Basic Information, Buprenorphine Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 101. PurduePharma Buprenorphine Transdermal Patches Product Offered
Table 102. PurduePharma Buprenorphine Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. PurduePharma Main Business
Table 104. PurduePharma Latest Developments
Table 105. Luye Pharma Basic Information, Buprenorphine Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 106. Luye Pharma Buprenorphine Transdermal Patches Product Offered
Table 107. Luye Pharma Buprenorphine Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Luye Pharma Main Business
Table 109. Luye Pharma Latest Developments
List of Figures
Figure 1. Picture of Buprenorphine Transdermal Patches
Figure 2. Buprenorphine Transdermal Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buprenorphine Transdermal Patches Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Buprenorphine Transdermal Patches Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Buprenorphine Transdermal Patches Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5mcg/h
Figure 10. Product Picture of 7.5mcg/h
Figure 11. Product Picture of 10mcg/h
Figure 12. Product Picture of 15 mcg/h
Figure 13. Product Picture of 20 mcg/h
Figure 14. Global Buprenorphine Transdermal Patches Sales Market Share by Type in 2021
Figure 15. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2017-2022)
Figure 16. Buprenorphine Transdermal Patches Consumed in Relieve Cancer Pain
Figure 17. Global Buprenorphine Transdermal Patches Market: Relieve Cancer Pain (2017-2022) & (K Units)
Figure 18. Buprenorphine Transdermal Patches Consumed in Other
Figure 19. Global Buprenorphine Transdermal Patches Market: Other (2017-2022) & (K Units)
Figure 20. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)
Figure 21. Global Buprenorphine Transdermal Patches Revenue Market Share by Application in 2021
Figure 22. Buprenorphine Transdermal Patches Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Buprenorphine Transdermal Patches Revenue Market Share by Company in 2021
Figure 24. Global Buprenorphine Transdermal Patches Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Buprenorphine Transdermal Patches Revenue Market Share by Geographic Region in 2021
Figure 26. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2017-2022)
Figure 27. Global Buprenorphine Transdermal Patches Revenue Market Share by Country/Region in 2021
Figure 28. Americas Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)
Figure 29. Americas Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)
Figure 30. APAC Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)
Figure 31. APAC Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)
Figure 32. Europe Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)
Figure 33. Europe Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)
Figure 36. Americas Buprenorphine Transdermal Patches Sales Market Share by Country in 2021
Figure 37. Americas Buprenorphine Transdermal Patches Revenue Market Share by Country in 2021
Figure 38. United States Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Buprenorphine Transdermal Patches Sales Market Share by Region in 2021
Figure 43. APAC Buprenorphine Transdermal Patches Revenue Market Share by Regions in 2021
Figure 44. China Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Buprenorphine Transdermal Patches Sales Market Share by Country in 2021
Figure 51. Europe Buprenorphine Transdermal Patches Revenue Market Share by Country in 2021
Figure 52. Germany Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Buprenorphine Transdermal Patches Revenue Market Share by Country in 2021
Figure 59. Egypt Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Buprenorphine Transdermal Patches in 2021
Figure 65. Manufacturing Process Analysis of Buprenorphine Transdermal Patches
Figure 66. Industry Chain Structure of Buprenorphine Transdermal Patches
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...